Literature DB >> 41539

Pharmacokinetics and metabolism of temazepam in man and several animal species.

H J Schwarz.   

Abstract

1 Absorption, excretion and detoxification of temazepam were investigated in man, mouse, rat and dog. Considerable interspecies variation was apparent with respect to excretion and metabolite patterns in blood and urine. Animal species were exposed to equal or greater concentrations of all the metabolites occurring in man. 2 Pharmacokinetics of temazepam in man were investigated in a single dose study at two dose levels, and in a multiple dose study. The results of both studies were analyzed and interpreted with the help of compartmental models. Values were obtained for excretion pattern (0-infinity), half lives (1.95, 0.5, 10.0 and 1.9 h), amounts in all compartments, and for steady-state conditions. 3 The bioavailability of the hard gelatin capsule dosage form was compared with that of a suspension serving as the ideal dosage form, and found to be acceptable.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41539      PMCID: PMC1429628          DOI: 10.1111/j.1365-2125.1979.tb00451.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

Review 1.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  Pharmacokinetic aspects of rectal formulations of temazepam.

Authors:  L M Hanff; W J Rutten
Journal:  Pharm World Sci       Date:  1996-06

4.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

5.  Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.

Authors:  F L Tse; F Ballard; J Skinn
Journal:  J Pharmacokinet Biopharm       Date:  1982-08

6.  Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam.

Authors:  T Okuma; H Matsuoka; Y Matsue; K Toyomura
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 7.  Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of the newer benzodiazepines.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; H R Ochs; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

9.  The effects of temazepam and ethanol on human psychomotor performance.

Authors:  G W Kunsman; J E Manno; M A Przekop; B R Manno; C M Kunsman
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  The effects of age and chronic liver disease on the elimination of temazepam.

Authors:  H Ghabrial; P V Desmond; K J Watson; A J Gijsbers; P J Harman; K J Breen; M L Mashford
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.